Novartis AG (NOVNN) Q4 2024 Earnings Report
MX:NOVNN Q4 2024 EPS Results
- Actual EPS
- MXN 36.99
- Consensus EPS
- MXN 33.72
- Beat/Miss
- Beat by +MXN 3.27
- One Year Ago EPS
- MXN 28.59
MX:NOVNN Q4 2024 Revenue Results
- Actual Revenue
- MXN 259.89B
- Expected Revenue
- MXN 239.86B
- Beat/Miss
- Beat by +MXN 20.03B
- YoY Revenue Growth
- +13.82%
Earnings Announcement Details
- Quarter
- Q4 2024
- Date
- 01/31/2025
- Time
- Before Open
- Conference Call
- Friday, January 31, 2025
MX:NOVNN Upcoming Earnings
Novartis AG's next earnings date is estimated for February 3, 2027, based on past reporting schedules.
Q4 2024 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q4 2024 Earnings Slide Deck
No slide deck is available for this earnings event.
Q4 2024 Earnings Call Summary
No earnings call summary is available for this earnings event.
MX:NOVNN Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 03, 2027 | 2026 (Q4) | 41.91- | 37.93 | ― | ― |
| Oct 27, 2026 | 2026 (Q3) | 42.4545.96 | 42.04 | 9.33% (+3.92) | |
| Jul 21, 2026 | 2026 (Q2) | 40.5145.03 | 45.21 | -0.41% (-0.19) | |
| Apr 28, 2026 | 2026 (Q1) | 39.3137.18 | 42.6 | -12.72% (-5.42) | |
| Feb 04, 2026 | 2025 (Q4) | 37.1637.93 | 36.99 | 2.53% (+0.93) | |
| Oct 28, 2025 | 2025 (Q3) | 42.4742.04 | 38.49 | 9.22% (+3.55) | |
| Jul 17, 2025 | 2025 (Q2) | 43.9345.21 | 36.81 | 22.84% (+8.41) | |
| Apr 29, 2025 | 2025 (Q1) | 39.5042.60 | 33.63 | 26.67% (+8.97) | |
| Jan 31, 2025 | 2024 (Q4) | 33.7236.99 | 28.59 | 29.41% (+8.41) | |
| Oct 29, 2024 | 2024 (Q3) | 36.2138.49 | 32.51 | 18.39% (+5.98) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
